Danaher logo
Danaher
DHR | NYSE
Chart Builder DCF Calculator
$230.15
-$2.87 (-1.23%)
At close: Nov 16, 2026, 4:00 PM ET
$229.91
-$0.24 (-0.10%)
After-hours: Nov 16, 2026, 6:08 PM ET

Danaher Company Profile

Company profile explained

Company Profile

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Key Executives

Name Position
Christopher Paul Riley Executive Vice President of Biotechnology Group & Chief Executive Officer of Cytiva
Julie Sawyer Montgomery President, Chief Executive Officer & Director
Jonathan Leiken Senior VP & Chief Legal Officer
Matthew E. Gugino Chief Financial Officer & Executive Vice President
Christopher Bouda Vice President & Chief Accounting Officer
Frank T. McFaden Vice President and Treasurer
Georgeann F. Couchara Senior Vice President of Human Resources
Gregory Milosevich Executive Vice President of Life Sciences Business
James F. O'Reilly Senior Vice President, Deputy General Counsel, Secretary & Chief Sustainability Officer
Jose-Carlos Gutierrez-Ramos Senior Vice President & Chief Science Officer
Matthew R. McGrew Executive Vice President
Mitchell Rales Co-Founder & Director
Rachel Marie Vatnsdal Olson Vice President of Investor Relations
Rainer Blair Senior Advisor
Steven Rales Co-Founder & Chairman

Latest SEC Filings

Date Type Title
Oct 29, 2026 4 Filing
Oct 29, 2026 4 Filing
Oct 21, 2026 8-K Current Report
Oct 21, 2026 10-Q Quarterly Report
Oct 16, 2026 3 Filing
Oct 16, 2026 3 Filing
Oct 14, 2026 4 Filing
Oct 14, 2026 4 Filing
Oct 13, 2026 8-K Current Report
Oct 02, 2026 3 Filing
View All SEC Filings ➞
Danaher
Danaher logo
Country United States
IPO Date Dec 29, 1978
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 59,000
CEO Julie Sawyer Montgomery

Contact Details

2200 Pennsylvania Avenue, NW Washington, DC 20037-1701 United States

Stock Details

Ticker Symbol DHR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000313616
CUSIP Number 235851102
ISIN Number US2358511028
SIC Code 3823

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.